David Shaw’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-285,932
| Closed | -$11.2M | – | 4672 |
|
|
2023
Q2 | $11.2M | Buy |
285,932
+79,596
| +39% | +$2.81M | 0.01% | 1243 |
|
|
2023
Q1 | $5.02M | Sell |
206,336
-606,631
| -75% | -$13.3M | 0.01% | 1932 |
|
|
2022
Q4 | $17.4M | Buy |
812,967
+726,378
| +839% | +$15.5M | 0.02% | 1019 |
|
|
2022
Q3 | $1.55M | Buy |
86,589
+67,526
| +354% | +$886K | ﹤0.01% | 3229 |
|
|
2022
Q2 | $183K | Buy |
+19,063
| New | +$239K | ﹤0.01% | 4577 |
|
|
2022
Q1 | – | Sell |
-371,728
| Closed | -$6.22M | – | 6127 |
|
|
2021
Q4 | $6.22M | Buy |
+371,728
| New | +$6.09M | 0.01% | 2143 |
|
|
2021
Q1 | – | Sell |
-16,355
| Closed | -$113K | – | 4588 |
|
|
2020
Q4 | $113K | Sell |
16,355
-13,665
| -46% | -$87.4K | ﹤0.01% | 3808 |
|
|
2020
Q3 | $169K | Sell |
30,020
-278,782
| -90% | -$1.33M | ﹤0.01% | 3626 |
|
|
2020
Q2 | $1.57M | Sell |
308,802
-200,229
| -39% | -$834K | ﹤0.01% | 2599 |
|
|
2020
Q1 | $1.75M | Sell |
509,031
-132,557
| -21% | -$775K | ﹤0.01% | 2273 |
|
|
2019
Q4 | $5.5M | Sell |
641,588
-40,073
| -6% | -$143K | 0.01% | 1657 |
|
|
2019
Q3 | $763K | Hold |
681,661
| – | – | ﹤0.01% | 2978 |
|
|
2019
Q2 | $886K | Sell |
681,661
-900
| -0.1% | -$1.24K | ﹤0.01% | 2751 |
|
|
2019
Q1 | $962K | Sell |
682,561
-1,839,434
| -73% | -$2.57M | ﹤0.01% | 2630 |
|
|
2018
Q4 | $3.03M | Sell |
2,521,995
-109,122
| -4% | -$211K | ﹤0.01% | 1850 |
|
|
2018
Q3 | $6.21M | Sell |
2,631,117
-82,476
| -3% | -$206K | 0.01% | 1426 |
|
|
2018
Q2 | $7.41M | Buy |
2,713,593
+63,619
| +2% | +$176K | 0.01% | 1268 |
|
|
2018
Q1 | $7.26M | Buy |
2,649,974
+64,624
| +2% | +$187K | 0.01% | 1182 |
|
|
2017
Q4 | $8.07M | Buy |
2,585,350
+132,150
| +5% | +$371K | 0.01% | 1165 |
|
|
2017
Q3 | $6.92M | Buy |
2,453,200
+256,619
| +12% | +$693K | 0.01% | 1160 |
|
|
2017
Q2 | $5.62M | Buy |
2,196,581
+939,945
| +75% | +$2.56M | 0.01% | 1261 |
|
|
2017
Q1 | $4.6M | Buy |
1,256,636
+1,151,899
| +1,100% | +$4.87M | 0.01% | 1355 |
|
|
2016
Q4 | $506K | Buy |
104,737
+86,373
| +470% | +$2.56M | ﹤0.01% | 2846 |
|
|
2016
Q3 | $847K | Buy |
18,364
+2,068
| +13% | +$117K | ﹤0.01% | 2497 |
|
|
2016
Q2 | $832K | Buy |
+16,296
| New | +$810K | ﹤0.01% | 2519 |
|
|
2015
Q4 | – | Sell |
-12,780
| Closed | -$518K | – | 4017 |
|
|
2015
Q3 | $518K | Sell |
12,780
-2,313
| -15% | -$123K | ﹤0.01% | 3039 |
|
|
2015
Q2 | $786K | Buy |
15,093
+9,061
| +150% | +$451K | ﹤0.01% | 2871 |
|
|
2015
Q1 | $281K | Buy |
6,032
+1,532
| +34% | +$79.5K | ﹤0.01% | 3334 |
|
|
2014
Q4 | $202K | Buy |
+4,500
| New | +$189K | ﹤0.01% | 3805 |
|
David Shaw's ISEE Position: Q3 2023 in Review
David Shaw sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 285,932 shares — an estimated $11.2M sold.
David Shaw first reported a position in ISEE in Q4 2014 and held it in 29 quarters. The position peaked at $17.4M in Q4 2022. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.
- David Shaw reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
- David Shaw sold 285,932 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $11.2M.
- David Shaw first reported a position in IVERIC bio, Inc. Common Stock in Q4 2014 and held it in 29 quarters.
- David Shaw's IVERIC bio, Inc. Common Stock position peaked at $17.4M in Q4 2022.
- 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.
Based on D.E. Shaw & Co's 13F filing for Q3 2023, filed 14 Nov 2023.